Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
39.65
-1.82 (-4.39%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $113.95 million as of October 16, 2026. It is the 24,079th most valuable company in the world and the 3,966th biggest in the United States. Its market cap has increased by 27.14% in one year.
Market Cap
113.95M
Enterprise Value
25.33M
1-Year Change
27.14%
Global Rank
Country Rank
#3,966 United States
Category
ChartMarket Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $113.95M, a decrease of -69.89%. That is a compound annual growth rate of -18.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 113.95M | 22.22% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Humacyte | 119.18M |
| Outlook Therapeutics | 118.85M |
| Retension Pharmaceuticals | 117.23M |
| Voyager Therapeutics | 117.07M |
| NRx Pharmaceuticals | 112.48M |
| Seer, Inc. | 112.41M |
| Minerva Neurosciences | 112.21M |
| TuHURA Biosciences | 112.16M |